These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25206413)

  • 21. Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease.
    Sharma R; McMillan CR; Niles LP
    J Pineal Res; 2007 Oct; 43(3):245-54. PubMed ID: 17803521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-transplantation of GDNF-overexpressing neural stem cells and fetal dopaminergic neurons mitigates motor symptoms in a rat model of Parkinson's disease.
    Deng X; Liang Y; Lu H; Yang Z; Liu R; Wang J; Song X; Long J; Li Y; Lei D; Feng Z
    PLoS One; 2013; 8(12):e80880. PubMed ID: 24312503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation between dopaminergic response and motor behavior following intrastriatal, but not intravenous, transplant of bone marrow mononuclear stem cells in a mouse model of Parkinson's disease.
    Calice da Silva C; Azevedo BN; Machado DC; Zimmer ER; Martins LAM; da Costa JC
    Behav Brain Res; 2017 May; 324():30-40. PubMed ID: 28167338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
    Lapchak PA; Miller PJ; Collins F; Jiao S
    Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease.
    Glavaski-Joksimovic A; Virag T; Mangatu TA; McGrogan M; Wang XS; Bohn MC
    J Neurosci Res; 2010 Sep; 88(12):2669-81. PubMed ID: 20544825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
    Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F
    Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regenerative therapy in experimental parkinsonism: mixed population of differentiated mouse embryonic stem cells, rather than magnetically sorted and enriched dopaminergic cells provide neuroprotection.
    Tripathy D; Verma P; Nthenge-Ngumbau DN; Banerjee M; Mohanakumar KP
    CNS Neurosci Ther; 2014 Aug; 20(8):717-27. PubMed ID: 24954161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neural stem cells transplanted in a mouse model of Parkinson's disease differentiate to neuronal phenotypes and reduce rotational deficit.
    Ziavra D; Makri G; Giompres P; Taraviras S; Thomaidou D; Matsas R; Mitsacos A; Kouvelas ED
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):829-35. PubMed ID: 23131156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a multiple system atrophy model in rats using multitracer microPET.
    Yoon HH; Lee CS; Hong SH; Min J; Kim YH; Hwang O; Jeon SR
    Acta Neurochir (Wien); 2012 May; 154(5):935-40. PubMed ID: 21866326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
    Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.
    Mine Y; Hayashi T; Yamada M; Okano H; Kawase T
    Neurosurgery; 2009 Oct; 65(4):741-53; discussion 753. PubMed ID: 19834380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells.
    Apostolides C; Sanford E; Hong M; Mendez I
    Neuroscience; 1998 Mar; 83(2):363-72. PubMed ID: 9460746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells.
    Nishimura F; Yoshikawa M; Kanda S; Nonaka M; Yokota H; Shiroi A; Nakase H; Hirabayashi H; Ouji Y; Birumachi J; Ishizaka S; Sakaki T
    Stem Cells; 2003; 21(2):171-80. PubMed ID: 12634413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat.
    Yang M; Stull ND; Berk MA; Snyder EY; Iacovitti L
    Exp Neurol; 2002 Sep; 177(1):50-60. PubMed ID: 12429210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrastriatal transplantation of stem cells from human exfoliated deciduous teeth reduces motor defects in Parkinsonian rats.
    Zhang N; Lu X; Wu S; Li X; Duan J; Chen C; Wang W; Song H; Tong J; Li S; Liu Y; Kang X; Wang X; Han F
    Cytotherapy; 2018 May; 20(5):670-686. PubMed ID: 29576501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
    Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
    Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease.
    Hedlund E; Pruszak J; Lardaro T; Ludwig W; Viñuela A; Kim KS; Isacson O
    Stem Cells; 2008 Jun; 26(6):1526-36. PubMed ID: 18388307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
    Ye M; Wang XJ; Zhang YH; Lu GQ; Liang L; Xu JY; Chen SD
    Brain Res; 2007 Apr; 1142():206-16. PubMed ID: 17336273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model.
    Yuan Y; Tang X; Bai YF; Wang S; An J; Wu Y; Xu ZD; Zhang YA; Chen Z
    Theranostics; 2018; 8(17):4679-4694. PubMed ID: 30279731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.